During this process, laboratories that carry out tests for the approval and release of the drugs are also evaluated. The FDA does not rely exclusively on the inspection reports of the German authority. The basis for the inspections are the GMP requirements laid down by US legislation. These specifications may differ from the European specifications.
During this year’s inspection of the microbiological laboratory of the BAV Institut, all GMP-relevant areas were checked and evaluated. The BAV Institut was able to meet all the requirements satisfactorily, so that there were no deviations or comments. Thus, BAV continues to be fully approved for the field of microbiological investigations.
Customers who are active in the US market or wish to expand there can therefore continue to rely fully on the reliable execution according to FDA specifications and thus on the results of BAV.
BAV Institut GmbH
Hans-Martin-Schleyer-Straße 25
77656 Offenburg
Tentamus Group GmbH
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 40 locations worldwide. More than 1,600 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany
www.tentamus.com
Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com
Assistenz der Geschäftsleitung BAV INSTITUT
Telefon: +49 (781) 969-470
E-Mail: info@bav-insitut.de
